These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12106675)

  • 1. Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists.
    Zalcman SS
    Brain Res; 2002 Jul; 944(1-2):157-64. PubMed ID: 12106675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
    Lapin IP; Rogawski MA
    Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of striatal neurons by joint blockade of D1 and D2 receptor subtypes in an in vitro model of cerebral hypoxia.
    Davis S; Brotchie J; Davies I
    Exp Neurol; 2002 Jul; 176(1):229-36. PubMed ID: 12093100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphine.
    Daugé V; Beslot F; Matsui T; Roques BP
    Neurosci Lett; 2001 Jun; 306(1-2):41-4. PubMed ID: 11403953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of MK-801 on contextual sensitization to climbing behavior and on development of tolerance to hypothermia induced by a single high dose of apomorphine.
    Yun JS; Kim HS; Lee MK; Oh KW; Jang CG; Park WK; Seong YH; Lee SC; Oh SK
    Pharmacol Res; 2001 Dec; 44(6):473-9. PubMed ID: 11735353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1 and D2 receptor antagonist injections in the prefrontal cortex selectively impair spatial learning in mice.
    Rinaldi A; Mandillo S; Oliverio A; Mele A
    Neuropsychopharmacology; 2007 Feb; 32(2):309-19. PubMed ID: 16900106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys.
    Lee B; Groman S; London ED; Jentsch JD
    Neuropsychopharmacology; 2007 Oct; 32(10):2125-34. PubMed ID: 17299511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural motor effects of MK-801 and DNQX parenteral administration in adult cats: dose-response analysis. Modulatory role of dopaminergic D1 and D2 antagonists on MK-801 induced motor behaviours.
    Motles E; Infante C; Gonzalez M
    Arch Ital Biol; 2000 Apr; 138(2):167-74. PubMed ID: 10782256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
    Hoque KE; West AR
    Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
    Neisewander JL; O'Dell LE; Redmond JC
    Brain Res; 1995 Feb; 671(2):201-12. PubMed ID: 7743209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR; Laruelle M; Mouradian MM
    J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic enhancement of excitatory synaptic transmission in layer II entorhinal neurons is dependent on D₁-like receptor-mediated signaling.
    Glovaci I; Caruana DA; Chapman CA
    Neuroscience; 2014 Jan; 258():74-83. PubMed ID: 24220689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF; Sheng J
    J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal and postnatal exposure to bisphenol a induces anxiolytic behaviors and cognitive deficits in mice.
    Tian YH; Baek JH; Lee SY; Jang CG
    Synapse; 2010 Jun; 64(6):432-9. PubMed ID: 20169576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitized increase of period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamine.
    Nikaido T; Akiyama M; Moriya T; Shibata S
    Mol Pharmacol; 2001 Apr; 59(4):894-900. PubMed ID: 11259635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists.
    Reeves R; Thiruchelvam M; Cory-Slechta DA
    Brain Res; 2004 May; 1008(2):155-67. PubMed ID: 15145752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of dexanabinol (HU-211), a novel NMDA receptor antagonist, with the dopaminergic system.
    Striem S; Bar-Joseph A; Berkovitch Y; Biegon A
    Eur J Pharmacol; 1997 Nov; 338(3):205-13. PubMed ID: 9424014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.